RxDoctor Payments Data

Arya Salas, MD

Plastic and Reconstructive Surgery · West Orange, NJNPI 1124189030

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,784 of the $5,480 with a category attached, or 87.3%. 31 manufacturers reported payments, led by Integra Lifesciences Corporation at 31.8% of the total.

$5,480in general payments, 2019–2025

Across 91 payments — averaging $60.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$2K
  • KCI USA, Inc.$779
  • Kerecis Limited$559
  • Musculoskeletal Transplant Foundation Inc.$333
  • AbbVie$295
  • Organogenesis Inc.$258
  • plus $2K from 25 others

What the payments were for

  • Travel & lodging$69613%
  • Food & beverage$4,78487%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,480 in reported general payments places this provider in the 80th percentile of 93 plastic and reconstructive surgery providers in New Jersey.

See all plastic and reconstructive surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$214,621
Medicare patients
132
Services billed
926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$125
Cefadroxil19$123

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in West Orange

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →